Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoporosis - Evidence based therapy].

H W Minne1, B Begerow, M Pfeifer

  • 1Institut für Klinische Osteologie "Gustav Pommer" und Klinik "Der Fürstenhof", Bad Pyrmont, Germany. iko_pyrmont@t-online.de

Zeitschrift Fur Gastroenterologie
|April 4, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole-genome sequencing reveals two prolonged simultaneous outbreaks involving Pseudomonas aeruginosa high-risk strains ST111 and ST235 with resistance to quaternary ammonium compounds.

The Journal of hospital infection·2024
Same author

[German S1 Guideline Long-/Post-COVID].

Pneumologie (Stuttgart, Germany)·2022
Same author

COVID-19 Lockdown Periods in 2020: Good Maintenance of Metabolic Control in Adults with Type 1 and Type 2 Diabetes.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2022
Same author

[Statement of the German Society for Pulmonology and Respiratory Medicine Regarding the Regulation to Use FFP and Surgical Masks in the General Population].

Pneumologie (Stuttgart, Germany)·2021
Same author

[S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19].

Pneumologie (Stuttgart, Germany)·2021
Same author

[Weaning in a Pandemic Situation - A Position Paper].

Pneumologie (Stuttgart, Germany)·2020
Same journal

[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

[Updated S3 guideline on ulcerative colitis].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
See all related articles

Calcium, vitamin D, bisphosphonates (alendronate, risedronate), and raloxifene offer the best evidence for preventing osteoporosis fractures. Other therapies have lower quality evidence, but hip protectors are effective.

Area of Science:

  • Gerontology and Geriatric Medicine
  • Pharmacology and Therapeutics
  • Orthopedics and Sports Medicine

Context:

  • Osteoporosis management has evolved, with multiple fracture prevention strategies now available.
  • The efficacy of various osteoporosis therapies is supported by varying levels of clinical evidence.
  • Systematic research is crucial for evaluating the quality of evidence for different treatments.

Purpose:

  • To systematically review and assess the quality of evidence for available osteoporosis therapies.
  • To identify treatments with proven fracture benefit based on randomized controlled trials.
  • To compare the evidence supporting different pharmacological and non-pharmacological interventions.

Summary:

  • Calcium and vitamin D supplementation, bisphosphonates (alendronate, risedronate), and selective estrogen receptor modulators (SERMs) like raloxifene demonstrate the strongest evidence for fracture prevention.

Related Experiment Videos

  • Therapies including fluorides, vitamin D metabolites, calcitonin, and etidronate have lower quality evidence supporting their use.
  • Currently, no evidence supports other pharmaceutical interventions, while hip protectors are effective for hip fracture prevention.

    • Impact:

    • Provides clinicians with evidence-based guidance for selecting optimal osteoporosis treatments.
    • Highlights the need for further research into therapies with limited supporting evidence.
    • Informs patient care by clarifying the efficacy of different fracture prevention strategies.